Literature DB >> 20668169

Opiate-positive immunoassay screen in a pediatric patient.

Joely A Straseski1, Andrew Stolbach, William Clarke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20668169      PMCID： PMC2975969          DOI： 10.1373/clinchem.2009.137596

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  3 in total

1.  Cross-reactivity of naloxone with oxycodone immunoassays: implications for individuals taking Suboxone.

Authors:  Amanda J Jenkins; Joseph G Poirier; Matthew P Juhascik
Journal:  Clin Chem       Date:  2009-04-30       Impact factor: 8.327

2.  Narcotic withdrawal syndrome caused by naltrexone.

Authors:  V W Tornabene
Journal:  Ann Intern Med       Date:  1974-12       Impact factor: 25.391

3.  American Academy of Pediatrics Committee on Drugs: Naloxone dosage and route of administration for infants and children: addendum to emergency drug doses for infants and children.

Authors: 
Journal:  Pediatrics       Date:  1990-09       Impact factor: 7.124
  3 in total
  1 in total

1.  ACMT Position Statement: Interpretation of Urine Opiate and Opioid Tests.

Authors:  Andrew Stolbach; Nicholas Connors; Lewis Nelson; Ken Kulig
Journal:  J Med Toxicol       Date:  2021-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.